Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Revenue (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Revenue for 3 consecutive years, with $94360.0 as the latest value for Q4 2025.

  • Quarterly Revenue fell 10.34% to $94360.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $456021.0 through Dec 2025, down 25.96% year-over-year, with the annual reading at $456021.0 for FY2025, 25.96% down from the prior year.
  • Revenue hit $94360.0 in Q4 2025 for Mangoceuticals, up from $84246.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $245160.0 in Q3 2023 to a low of $84246.0 in Q3 2025.
  • Historically, Revenue has averaged $150282.2 across 3 years, with a median of $137302.5 in 2023.
  • Biggest YoY gain for Revenue was 112.56% in 2024; the steepest drop was 56.93% in 2024.
  • Year by year, Revenue stood at $244374.0 in 2023, then tumbled by 56.93% to $105247.0 in 2024, then decreased by 10.34% to $94360.0 in 2025.
  • Business Quant data shows Revenue for MGRX at $94360.0 in Q4 2025, $84246.0 in Q3 2025, and $168109.0 in Q2 2025.